Headquartered in New York, NY Fiscal year ends December NYSE: CNS cohenandsteers.com
Cohen & Steers, Inc. (NYSE: CNS) is a global investment manager specializing in real assets and alternative income strategies. The firm manages approximately $100.1 billion in assets across listed and private real estate, preferred securities, infrastructure, resource equities, commodities, and multi-strategy solutions. Founded in 1986, it serves institutional and retail clients through open-end mutual funds, closed-end funds, institutional advisory and subadvisory accounts, active ETFs, European SICAVs, and a non-traded REIT (CNSREIT). The firm operates a growing active ETF platform with six funds exceeding $1 billion in AUM and a European listed fund platform surpassing $2 billion. Cohen & Steers has offices in New York, London, Dublin, Hong Kong, Tokyo, and Singapore. Updated
CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin glioblastoma story. But here’s what you should actually be watching. Holders captured the move;…
In the past week or so, renowned investors Carl Icahn and Mario Gabelli led some huge insider buying. These were not the only notable purchases though.
Cohen & Steers, Inc. (NYSE: CNS) is a global investment manager specializing in real assets and alternative income strategies.
24/7 Wall St.'s 12-month price target for CNS is $79.71, rated Buy. The Wall Street consensus target is $76.33. CNS price prediction →
